Review
Dapagliflozin in Metabolic Dysfunction-Associated Steatotic Liver Disease: Clinical Evidence and Therapeutic Potential
Euroasian Journal of Hepato-gastroenterology
- Dapagliflozin
- SLC5A2
- Metabolic dysfunction-associated steatotic liver disease
- Metabolic dysfunction-associated steatohepatitis
- Cirrhosis
- Humans
The paper
Department of Gastroenterology and Hepatology · Department of Medical Affairs
Euroasian Journal of Hepato-gastroenterology · 1 Jan 2026 · CC BY-NC